0.25 mg Wegovy: What to Know About Your Starting Dose

Wegovy contains the active substance semaglutide, a GLP-1 receptor agonist. According to information in the electronic Medicines Compendium (eMC), Wegovy is typically introduced at a low dose and then adjusted over time under prescriber direction. The 0.25 mg starting strength is designed to help minimise the gastrointestinal side effects — such as nausea, indigestion, or loose stools — that some people experience when they first begin treatment.

The dose stages

Wegovy is available in several strengths. Commonly referenced dose stages include 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. Movement between these stages — for example, moving up to the 1.7 mg stage — is always a decision made by your prescriber based on how you are responding to treatment and how well the current dose is tolerated. No one should adjust their dose without guidance from their prescriber or doctor.

What 0.25 mg does and does not mean

At 0.25 mg, some people notice early changes in appetite or food noise; others do not feel much difference yet. Neither experience is unusual. The starting dose is an introduction phase, not a measure of how the medicine will ultimately work for you. Your prescriber is the right person to discuss how things are progressing and whether any adjustment is appropriate.

If you are curious about how the dose schedule compares across GLP-1 medicines, you may find it useful to read about the starting dose approach for Mounjaro (tirzepatide) for context. And for detail on the later Wegovy stages, see the 1.7 mg Wegovy dose guide.

On cost-related searches such as the cheapest 2.4 mg Wegovy or questions about 1 mg or 1.7 mg Wegovy pricing: GLP Trackr does not sell, supply, or source any medication, and we do not publish prices for prescription medicines. For questions about cost and access, speak with your prescriber or a registered pharmacy in your country.

When you are in the early stages of a titration schedule, keeping an accurate record of every dose matters — and that is exactly where GLP Trackr is built to help. The app's dose logging feature lets you record each weekly injection: the strength you took, the date, and the time. Over weeks and months, that log becomes a clear, reliable history you can bring to your prescriber appointments.

Alongside dose logging, GLP Trackr includes gentle reminders so a weekly injection is never accidentally forgotten — particularly useful during the early weeks when the routine is still new. If you ever miss a dose or have a question about what to do, always refer to the patient information leaflet that came with your pen or contact your prescriber or doctor directly. The app can help you log a missed dose so it is on record to discuss, but any decision about how to proceed belongs with your healthcare professional.

You can also use the side-effect tracker to note anything you experience at each dose stage — nausea, fatigue, or other changes — and watch whether patterns shift as your body settles in. That kind of personal record is genuinely useful to share with your prescriber. For a broader view of managing your Wegovy journey, the full GLP-1 dosing and tracking guide covers the wider picture.

A note on safety: all decisions about your Wegovy dose — including whether to stay at 0.25 mg longer, move to the next stage, or pause — should be made with your prescriber. GLP Trackr supports your journey with tracking and logging; it is not a substitute for clinical guidance. If you experience symptoms that are severe, persistent, or worrying, contact your healthcare professional promptly. Any side effects worth reporting can be submitted to your national reporting scheme (such as the UK's Yellow Card scheme) and discussed with your doctor.

Ready to keep your weekly dose on track? GLP Trackr is free to try for 7 days — download it on the App Store or Google Play and start building your dose history from day one.